Comparison of Outcomes With Multifocal Intraocular Lenses
NCT ID: NCT02678962
Last Updated: 2024-07-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
90 participants
INTERVENTIONAL
2016-02-29
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of the Visual Performance After Implantation of Multifocal Lens
NCT03586271
Visual Acuity After the Combined Binocular Implantation of +2.0 Diopters and +3.0 Diopters Oculentis Multifocal Intraocular Lenses.
NCT02633228
Visual Performance of Multifocal Intraocular Lenses
NCT04913792
Multifocal Contact Lenses vs Bifocal Spectacles for Congenital Cataracts
NCT03260764
Multifocal vs Monofocal IOL in Congenital Cataract Surgery
NCT04872829
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SN6AD1 group
Bilateral cataract surgery with implantation of SN6AD1 multifocal IOLs
SN6AD1
Bilateral cataract surgery with implantation of SN6AD1 multifocal IOLs
SBL-3 group
Bilateral cataract surgery with implantation of SBL-3 multifocal IOLs
SBL-3
Bilateral cataract surgery with implantation of SBL-3 multifocal IOLs
LS-313 MF30 group
Bilateral cataract surgery with implantation of LS-313 MF30 multifocal IOLs
LS-313 MF30
Bilateral cataract surgery with implantation of LS-313 MF30 multifocal IOLs
AT LISA tri 839 MP group
Bilateral cataract surgery with implantation of AT LISA tri 839 MP multifocal IOLs
AT LISA tri 839 MP
Bilateral cataract surgery with implantation of AT LISA tri 839 MP multifocal IOLs
ART group
Bilateral cataract surgery with implantation of ART toric multifocal IOLs
ART
Bilateral cataract surgery with implantation of ART toric multifocal IOLs
LS-313 MF30T group
Bilateral cataract surgery with implantation of LS-313 MF30T toric multifocal IOLs
LS-313 MF30T
Bilateral cataract surgery with implantation of LS-313 MF30T toric multifocal IOLs
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SN6AD1
Bilateral cataract surgery with implantation of SN6AD1 multifocal IOLs
SBL-3
Bilateral cataract surgery with implantation of SBL-3 multifocal IOLs
LS-313 MF30
Bilateral cataract surgery with implantation of LS-313 MF30 multifocal IOLs
AT LISA tri 839 MP
Bilateral cataract surgery with implantation of AT LISA tri 839 MP multifocal IOLs
ART
Bilateral cataract surgery with implantation of ART toric multifocal IOLs
LS-313 MF30T
Bilateral cataract surgery with implantation of LS-313 MF30T toric multifocal IOLs
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with bilateral age related cataracts, require bilateral cataract phacoemulsification combined Intraocular Lens implantation;
* Willing to undergo second eye surgery within 7 days after first eye surgery;
* The potential postoperative visual acuity of 20/40 or better in both eyes;
* Preoperative measurement of corneal astigmatism indicate the subjects are suitable for multifocal intraocular lenses implantation;
* Capability to understand the informed consent and willing and able to attend study
Exclusion Criteria
* Preexisting systemic diseases or conditions that may confound the results of the study;
* Previous ocular surgery history or ocular trauma that may confound the results of the study;
* Require combined surgery that may confound the results of the study;
* Previous participation in other clinical trial within 30 days of this study start;
* Systemic or ocular medications that may confound the outcome of the intervention
* Pregnant, lactating, or planning to become pregnant during the course of the trial;
40 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wenzhou Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
A-Yong Yu
Clinical Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
AYong Yu, MD. PhD.
Role: PRINCIPAL_INVESTIGATOR
Wenzhou Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Eye Hispital of Wenzhou Medical University
Wenzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MIOLs2016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.